Researchers in Germany believe that MR imaging should be included among the World Health Organization’s options for diagnosing sporadic Creutzfeldt-Jakob disease (sCJD), which is associated with exposure to mad cow disease.
Researchers in Germany believe that MR imaging should be included among the World Health Organization's options for diagnosing sporadic Creutzfeldt-Jakob disease (sCJD), which is associated with exposure to mad cow disease.
Principal investigator Dr. Henriette Tschampa and colleagues at the Clinical University of Bonn enrolled 193 consecutive patients suspected of having the condition. All the patients had previously been examined by a neurologist from the German CJD Surveillance Unit in a study that took place between 1999 and 2002.
In addition to evaluating MRI's utility, the investigators paired study results with those of electroencephalography and 14-3-3 protein analysis. They found that MR provided a reliable diagnosis of sCJD.
In 442 scans, MR's sensitivity and specificity were nearly 70% and 85%, respectively, in patients with a clinical or postmortem sCJD diagnosis. Sensitivity and specificity for EEG and 14-3-3 protein analysis were 32% and 94%, and 91% and 44%, respectively.
MR's imaging protocol included T2-weighted, FLAIR, diffusion-weighted, and proton density-weighted sequences. Three independent observers compared and rated the studies and reached high agreement.
Even though MR's interpretation could require some effort, it provides useful information that could narrow down an sCJD diagnosis, it is 100% noninvasive, and it has an edge over diagnostic alternatives plagued by high false-positive rates. MRI is not among WHO's sanctioned diagnostic tests for sCJD, but the time to incorporate it has come, Tschampa said.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Can MRI-Based Deep Learning Improve Risk Stratification in PI-RADS 3 Cases?
January 30th 2025In external validation testing, a deep learning model demonstrated an average AUC of 87.6 percent for detecting clinically significant prostate cancer (csPCA) on prostate MRI for patients with PI-RADS 3 assessments.